Lung Cancers Completed Phase 2 / 3 Trials for Lidocaine (DB00281)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01955824A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible BronchoscopyTreatment